Harbor Investment Advisory’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-72
Closed -$4.78K 1262
2025
Q4
$4.78K Sell
72
-965
-93% -$62.4K ﹤0.01% 1062
2025
Q3
$69.8K Sell
1,037
-148
-12% -$11.7K 0.01% 572
2025
Q2
$103K Sell
1,185
-2,779
-70% -$218K 0.01% 479
2025
Q1
$271K Buy
3,964
+3,500
+754% +$286K 0.03% 326
2024
Q4
$36.1K Sell
464
-200
-30% -$14.8K ﹤0.01% 651
2024
Q3
$44.5K Sell
664
-288
-30% -$23.6K ﹤0.01% 614
2024
Q2
$108K Buy
952
+88
+10% +$11.1K 0.01% 426
2024
Q1
$120K Buy
864
+100
+13% +$12.6K 0.01% 413
2023
Q4
$94.8K Sell
764
-629
-45% -$64.3K 0.01% 432
2023
Q3
$130K Sell
1,393
-1,049
-43% -$118K 0.02% 367
2023
Q2
$314K Sell
2,442
-924
-27% -$112K 0.04% 279
2023
Q1
$391K Sell
3,366
-66
-2% -$7.39K 0.06% 248
2022
Q4
$389K Buy
3,432
+68
+2% +$7.47K 0.06% 240
2022
Q3
$271K Sell
3,364
-1,204
-26% -$102K 0.04% 282
2022
Q2
$340K Buy
4,568
+524
+13% +$47.8K 0.05% 247
2022
Q1
$517K Buy
4,044
+1,700
+73% +$186K 0.07% 218
2021
Q4
$315K Sell
2,344
-740
-24% -$106K 0.04% 290
2021
Q3
$422K Sell
3,084
-1,532
-33% -$193K 0.06% 250
2021
Q2
$493K Buy
4,616
+724
+19% +$69.5K 0.07% 228
2021
Q1
$350K Buy
3,892
+2,764
+245% +$259K 0.05% 253
2020
Q4
$104K Buy
1,128
+72
+7% +$6.43K 0.02% 444
2020
Q3
$109K Sell
1,056
-156
-13% -$16.3K 0.02% 367
2020
Q2
$123K Buy
1,212
+12
+1% +$1.07K 0.03% 328
2020
Q1
$81K Buy
1,200
+796
+197% +$49.5K 0.02% 339
2019
Q4
$22K Buy
+404
New +$19.2K 0.01% 528

Other funds holding DXCM

Harbor Investment Advisory's DXCM Position: Q1 2026 in Review

Harbor Investment Advisory sold out of DexCom (DXCM) in Q1 2026, closing a stake of 72 shares — an estimated $4.78K sold.

Harbor Investment Advisory first reported a position in DXCM in Q4 2019 and held it in 25 quarters. The position peaked at $517K in Q1 2022. 959 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Harbor Investment Advisory reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Harbor Investment Advisory sold 72 DexCom shares in Q1 2026, an estimated $4.78K.
  • Harbor Investment Advisory first reported a position in DexCom in Q4 2019 and held it in 25 quarters.
  • Harbor Investment Advisory's DexCom position peaked at $517K in Q1 2022.
  • 959 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Harbor Investment Advisory's 13F filing for Q1 2026, filed 23 Apr 2026.